🟢 Surgepays is trading 11% up today after receiving a 180-day Nasdaq bid-price extension

Surgepays is trading at $0.15, up +11.01%, after receiving an additional 180 days to regain Nasdaq’s minimum-bid-price compliance.

• The extension runs through March 22, 2027, to meet Nasdaq’s $1.00 minimum-bid-price requirement.
• The company also regained compliance with Nasdaq’s stockholders’ equity requirement.
• Intraday volume information was not available in the sources reviewed.